title: Down-regulation of NADPH-diaphorase (nitric oxide synthase) may account for the pharmacological activities of Cu(II)2 (3,5-diisopropylsalicylate)4.
authors.forename: J G
authors.initials: JG
authors.lastname: Baquial
authors.forename: J R
authors.initials: JR
authors.lastname: Sorenson
mesh_terms: D015536:Down-Regulation; D007004:Hypoglycemic Agents / Q000494:pharmacology; D009252:NADPH Dehydrogenase / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D012459:Salicylates / Q000494:pharmacology*
chemical_list: D007004:Hypoglycemic Agents; D012459:Salicylates; C030865:copper bis(3,5-diisopropylsalicylate); D019001:Nitric Oxide Synthase; D009252:NADPH Dehydrogenase